Variation in Circulating Betatrophin/ ANGPTL8 Levels in Normal and Overweight/Obese Pregnant Women
Introduction: Betatrophin as hepatokine and adipokine influences
glucose homeostasis and implicates in the pathophysiological
process... See more
Introduction: Betatrophin as hepatokine and adipokine influences
glucose homeostasis and implicates in the pathophysiological
process of obesity and pregnancy. Various studies suggest that
metabolic changes in normal weight/lean Pregnant women (PL)
are significantly different from overweight/obese pregnant women
(PO). However, the exact mechanism of how pre-gravid Body
mass index (preBMI) affects betatrophin levels during normal
pregnancy and the relationship of betatrophin to other clinical
variables in PL and in PO have not been elucidated.
Aim: To elucidate the effect of preBMI on betatrophin level in the
initial three trimesters of pregnancy, and to determine the possible
correlation between betatrophin and lipid profile parameters/
thyroid profile.
Materials and Methods: The cross-sectional study was carried
out from December 2016 to May 2017 at Maternity Hospital,
Zakho City, Kurdistan Region (Iraq). Betatrophin levels were
estimated in 59 pregnant women in initial three trimester of
pregnancy. Among 32 PL (pre BMI≤24.9 kg/m2) and 27 PO (pre
BMI>25 kg/m2), 10 and 8 were in First trimester (FT), 10 and 10
were in Second trimester (ST), 12 and 9 were in Third trimester
(TT) respectively. Ten Non-pregnant normal weight/lean (NPL)
(BMI≤24.9 kg/m2) and 12 Non-pregnant overweight/obese
(NPO) (BMI>25 kg/m2) healthy married women of reproductive
age were selected as controls.
Serum total betatrophin, total triiodothyronine (T3), total-thyroxin
(T4), thyroid stimulating hormone (TSH), and estradiol (E2) were
estimated by Enzyme linked immunosorbent assay (ELISA)
and Triglyceride (TG) was estimated by the glycerophosphate
oxidase colorimetric method. One-way analysis of variance
(ANOVA), Welch test, Kruskal Wallis test, Games-Howell test,
Independent t-test, Mann-Whitney test, and Pearson/Spearman
correlation analysis were performed to assess the parameters.
The p-value <0.05 was considered statistically significant.
Results: Betatrophin levels were elevated by 21.3% in the PL
as compared to NPL group. The raised levels in FT gradually
decreased towards the end of gestation. Conversely, in the PO,
betatrophin was significantly decreased as compared to NPO
group (p-value=0.03). In FT, betatrophine showed a significant
decline compared to ST, TT and NPO groups (p= 0.017, 0.006
and 0.001 respectively). In PL, betatrophin was correlated
with TSH in ST (r=0.721, p=0.019) and with T3 in TT (r=0.759,
p=0.004). In NPL, betatrophin correlated with T3 (r=0.823,
p=0.003). In PO, Betatrophin correlated with T3 (r=0.433,
p=0.024), T4 (r=0.499, p=0.008), E2 (r=0.609, p=0.001),
TG (r=0.570, p=0.002) and Gestational weight gained (GWG)
(r=0.676, p=0.0001). TG levels were elevated in all trimesters in
PO than in PL.
Conclusion: Our results highlight the potential involvement of
T3 and TSH in regulating betatrophin levels during pregnancy.
Therefore, T3 and TSH levels beside TG level should be
taken into consideration when interpreting clinical studies
of betatrophin. Depending upon the preBMI; betatrophin
change in different ways in PL and PO women. Conversely
to PL, betatrophin levels increased during pregnancy in PO,
and correlated with TG. Therefore, maintaining an ideal weight
before pregnancy is recommended to avoid pregnancy related
complications such as hypertriglyceridemia and insulin
resistance.
2019-08